Anne A Eaton (Anne Eaton)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 14

Top Topics

Allogeneic Hematopoietic Stem Cell Transplantation

Acute Lymphoblastic Leukemia

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Clinical trials (London, England)

Statistics in medicine

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Anne A Eaton
Statistical approaches for component-wise censored composite endpoints. Clinical trials (London, England) (2024)
Anne A Eaton, Dorothy K Hatsukami, Irina Stepanov, Peter G Shields, Dana Mowls Carroll
Estimating the causal effect of filter ventilation levels in cigarettes on past 30-day smoking. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco (2024)
Shernan G Holtan, Constanza Savid-Frontera, Kelly Walton, Anne A Eaton, Connor Demorest, Andrea Hoeschen, Ling Zhang, Kayla M Reid, Tony Kurian, Zena Sayegh, Estefania Julia, Joseph E Maakaron, Veronika Bachanova, Najla El Jurdi, Margaret L MacMillan, Daniel J Weisdorf, Martin Felices, Jeffrey S Miller, Bruce R Blazar, Marco L Davila, Brian C Betts
Human effectors of acute and chronic GVHD overexpress CD83 and predict mortality. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Shernan G Holtan, Constanza Savid-Frontera, Kelly Walton, Anne A Eaton, Connor Demorest, Andrea Hoeschen, Ling Zhang, Kayla M Reid, Tony Kurian, Zena Sayegh, Estefania Julia, Joseph E Maakaron, Veronika Bachanova, Najla El Jurdi, Margaret L MacMillan, Daniel J Weisdorf, Martin Felices, Jeffrey S Miller, Bruce R Blazar, Marco L Davila, Brian C Betts
Human Effectors of Acute and Chronic GVHD Overexpress CD83 and Predict Mortality. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (6) (2023)
Shernan G Holtan, Constanza Savid-Frontera, Kelly Walton, Anne A Eaton, Connor Demorest, Andrea Hoeschen, Ling Zhang, Kayla M Reid, Tony Kurian, Zena Sayegh, Estefania Julia, Joseph E Maakaron, Veronika Bachanova, Najla El Jurdi, Margaret L MacMillan, Daniel J Weisdorf, Martin Felices, Jeffrey S Miller, Bruce R Blazar, Marco L Davila, Brian C Betts
Human Effectors of Acute and Chronic GVHD Overexpress CD83 and Predict Mortality. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (6) (2023)
Shernan G Holtan, Constanza Savid-Frontera, Kelly Walton, Anne A Eaton, Connor Demorest, Andrea Hoeschen, Ling Zhang, Kayla M Reid, Tony Kurian, Zena Sayegh, Estefania Julia, Joseph E Maakaron, Veronika Bachanova, Najla El Jurdi, Margaret L MacMillan, Daniel J Weisdorf, Martin Felices, Jeffrey S Miller, Bruce R Blazar, Marco L Davila, Brian C Betts
Human Effectors of Acute and Chronic GVHD Overexpress CD83 and Predict Mortality. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (6) (2023)
Shernan G Holtan, Constanza Savid-Frontera, Kelly Walton, Anne A Eaton, Connor Demorest, Andrea Hoeschen, Ling Zhang, Kayla M Reid, Tony Kurian, Zena Sayegh, Estefania Julia, Joseph E Maakaron, Veronika Bachanova, Najla El Jurdi, Margaret L MacMillan, Daniel J Weisdorf, Martin Felices, Jeffrey S Miller, Bruce R Blazar, Marco L Davila, Brian C Betts
Human effectors of acute and chronic GVHD overexpress CD83 and predict mortality. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Shernan G Holtan, Constanza Savid-Frontera, Kelly Walton, Anne A Eaton, Connor Demorest, Andrea Hoeschen, Ling Zhang, Kayla M Reid, Tony Kurian, Zena Sayegh, Estefania Julia, Joseph E Maakaron, Veronika Bachanova, Najla El Jurdi, Margaret L MacMillan, Daniel J Weisdorf, Martin Felices, Jeffrey S Miller, Bruce R Blazar, Marco L Davila, Brian C Betts
Human Effectors of Acute and Chronic GVHD Overexpress CD83 and Predict Mortality. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (6) (2023)
Anne A Eaton, Emily C Zabor
Analysis of composite endpoints with component-wise censoring in the presence of differential visit schedules. Statistics in medicine 41 (9) (2022)
Heather Stefanski, Anne A Eaton, Christina Baggott, Jenna Rossoff, Michael R Verneris, Amy K Keating, Snehit Prabhu, Holly L Pacenta, Christine L Phillips, Julie-An Talano, Amy Moskop, Steven P Margossian, Gary Doug Myers, Nicole A Karras, Patrick A Brown, Muna Qayed, Michelle L Hermiston, Prakash Satwani, Christa Krupski, Rachel Wilcox, Cara A Rabik, Vanessa A Fabrizio, Vasant Chinnabhandar, A Yasemin Goksenin, Emily Egeler, Sharon Mavroukakis, Kevin J Curran, Crystal L Mackall, Theodore W Laetsch, Liora M Schultz
Higher doses of tisagenlecleucel associate with improved outcomes: a report from the pediatric real-world CAR consortium. Blood advances (2022)
Liora M Schultz, Anne A Eaton, Christina Baggott, Jenna Rossoff, Snehit Prabhu, Amy K Keating, Christa Krupski, Holly L Pacenta, Christine L Philips, Julie-An Talano, Amy Moskop, Susanne H C Baumeister, Gary Douglas Myers, Nicole A Karras, Patrick A Brown, Muna Qayed, Michelle L Hermiston, Prakash Satwani, Rachel Wilcox, Cara A Rabik, Vanessa A Fabrizio, Vasant Chinnabhandar, Michael Kunicki, Sharon Mavroukakis, Emily Egeler, Yimei Li, Crystal L Mackall, Kevin J Curran, Michael R Verneris, Theodore W Laetsch, Heather Stefanski
Outcomes After Nonresponse and Relapse Post-Tisagenlecleucel in Children, Adolescents, and Young Adults With B-Cell Acute Lymphoblastic Leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Anne A Eaton, Yifei Sun, James Neaton, Xianghua Luo
Nonparametric estimation in an illness-death model with component-wise censoring. Biometrics (2021)
Anne A Eaton, Terry Therneau, Jennifer G Le-Rademacher
Designing clinical trials with (restricted) mean survival time endpoint: Practical considerations. Clinical trials (London, England) 17 (3) (2020)
Ales Kotalik, Anne A Eaton, Qinshu Lian, Carlos Serrano, John Connett, James D Neaton
A win ratio approach to the re-analysis of Multiple Risk Factor Intervention Trial. Clinical trials (London, England) 16 (6) (2019)